Loading clinical trials...
Loading clinical trials...
BACKGROUND/OBJECTIVE: Quantitative urine screening for mucopolysaccharides (MPS) has been the primary method for detecting mucopolysaccharidoses in children. This method may not be sufficiently sensit...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Children's Hospitals and Clinics of Minnesota
Collaborators
NCT03604835 · Mucopolysaccharidosis VII, MPS VII, and more
NCT03153319 · Mucopolysaccharidosis I, Mucopolysaccharidosis II, and more
NCT03204370 · Mucopolysaccharidosis IV A
NCT03632213 · Mucopolysaccharidosis IV A, Mucopolysaccharidosis VI, and more
NCT03370653 · Mucopolysaccharidosis VI
Children's Hospitals and Clinics of Minnesota
Minneapolis, Minnesota
Gillette Children's Specialty Healthcare
Saint Paul, Minnesota
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions